These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28575150)

  • 1. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
    Chuffa LGA; Reiter RJ; Lupi LA
    Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma.
    Chuffa LG; Alves MS; Martinez M; Camargo IC; Pinheiro PF; Domeniconi RF; Júnior LA; Martinez FE
    Endocr Relat Cancer; 2016 Feb; 23(2):65-76. PubMed ID: 26555801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
    Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
    J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
    Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
    BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
    Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomic landscape of ovarian cancer cells in response to melatonin.
    Cesário RC; Gaiotte LB; Cucielo MS; Silveira HS; Delazari Dos Santos L; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
    Life Sci; 2022 Apr; 294():120352. PubMed ID: 35074409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma.
    Chuffa LG; Lupi Júnior LA; Seiva FR; Martinez M; Domeniconi RF; Pinheiro PF; Dos Santos LD; Martinez FE
    J Proteome Res; 2016 Oct; 15(10):3872-3882. PubMed ID: 27604906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.
    Lu KH; Lin RC; Yang JS; Yang WE; Reiter RJ; Yang SF
    Cells; 2019 Dec; 8(12):. PubMed ID: 31842295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro.
    Kalkunte S; Swamy N; Dizon DS; Brard L
    J Exp Ther Oncol; 2006; 5(4):287-300. PubMed ID: 17024969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review.
    Bizzarri M; Proietti S; Cucina A; Reiter RJ
    Expert Opin Ther Targets; 2013 Dec; 17(12):1483-96. PubMed ID: 24032643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs.
    Shen CJ; Chang CC; Chen YT; Lai CS; Hsu YC
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option.
    Smolle E; Taucher V; Petru E; Haybaeck J
    Anticancer Res; 2014 Apr; 34(4):1519-30. PubMed ID: 24692678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells.
    Silveira HS; Cesário RC; Vígaro RA; Gaiotte LB; Cucielo MS; Guimarães F; Seiva FRF; Zuccari DAPC; Reiter RJ; Chuffa LGA
    Mol Cell Endocrinol; 2024 Oct; 592():112296. PubMed ID: 38844096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
    Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
    Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
    Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
    J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.
    Kim JH; Jeong SJ; Kim B; Yun SM; Choi DY; Kim SH
    J Pineal Res; 2012 Mar; 52(2):244-52. PubMed ID: 22050627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
    Samanta S
    J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.